APA (7th ed.) Citation

Xiang, Y., Wang, K., Yu, H., Li, X., Cheng, Y., Wang, W., . . . Cheng, S. (2022). Transarterial chemoembolization plus a PD‐1 inhibitor with or without lenvatinib for intermediate‐stage hepatocellular carcinoma. Hepatology Research, 52(8), 721. https://doi.org/10.1111/hepr.13773

Chicago Style (17th ed.) Citation

Xiang, Yan‐Jun, et al. "Transarterial Chemoembolization Plus a PD‐1 Inhibitor with or Without Lenvatinib for Intermediate‐stage Hepatocellular Carcinoma." Hepatology Research 52, no. 8 (2022): 721. https://doi.org/10.1111/hepr.13773.

MLA (9th ed.) Citation

Xiang, Yan‐Jun, et al. "Transarterial Chemoembolization Plus a PD‐1 Inhibitor with or Without Lenvatinib for Intermediate‐stage Hepatocellular Carcinoma." Hepatology Research, vol. 52, no. 8, 2022, p. 721, https://doi.org/10.1111/hepr.13773.